Capital Research Global Investors
Institutional investor · Portfolio as of Q4 2018
Top Holdings417 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
ABBVIE INC | 173.6M | $16B | 5.6% | $66.47 | 0.00% | 1 qtr | New 98 |
MICROSOFT CORP | 109.9M | $11.2B | 3.9% | $93.93 | 0.00% | 1 qtr | New 88 |
META PLATFORMS INC-CLASS A | 69.8M | $9.1B | 3.2% | $132.28 | 0.00% | 1 qtr | New 88 |
ABBOTT LABORATORIES | 121.9M | $8.8B | 3.1% | $62.83 | 0.00% | 1 qtr | New 88 |
AMAZON.COM INC | 4.7M | $7.1B | 2.5% | $73.90 | 0.00% | 1 qtr | New 83 |
NETFLIX INC | 25.7M | $6.9B | 2.4% | $25.61 | 0.00% | 1 qtr | New 83 |
AMGEN INC | 35.1M | $6.8B | 2.4% | $154.81 | 0.00% | 1 qtr | New 83 |
BROADCOM INC | 25.3M | $6.4B | 2.2% | $21.01 | 0.00% | 1 qtr | New 83 |
ALPHABET INC-CL C | 5.1M | $5.3B | 1.8% | $51.47 | 0.00% | 1 qtr | New 73 |
VERIZON COMMUNICATIONS INC | 92.3M | $5.2B | 1.8% | $37.01 | 0.00% | 1 qtr | New 73 |
ALPHABET INC-CL A | 4.8M | $5B | 1.8% | $51.94 | 0.00% | 1 qtr | New 73 |
UNITEDHEALTH GROUP INC | 19.2M | $4.8B | 1.7% | $219.58 | 0.00% | 1 qtr | New 73 |
INTEL CORP | 97.6M | $4.6B | 1.6% | $40.23 | 0.00% | 1 qtr | New 73 |
GILEAD SCIENCES INC | 72.5M | $4.5B | 1.6% | $47.26 | 0.00% | 1 qtr | New 73 |
EOG RESOURCES INC | 45.7M | $4B | 1.4% | $64.11 | 0.00% | 1 qtr | New 73 |
EXXON MOBIL CORP | 55.4M | $3.8B | 1.3% | $48.91 | 0.00% | 1 qtr | New 73 |
PHILIP MORRIS INTERNATIONAL | 54.9M | $3.7B | 1.3% | $46.78 | 0.00% | 1 qtr | New 73 |
THERMO FISHER SCIENTIFIC INC | 15.9M | $3.6B | 1.2% | $218.44 | 0.00% | 1 qtr | New 73 |
GENERAL DYNAMICS CORP | 22.4M | $3.5B | 1.2% | $131.31 | 0.00% | 1 qtr | New 73 |
NIKE INC -CL B | 47.1M | $3.5B | 1.2% | $66.94 | 0.00% | 1 qtr | New 73 |
Capital Research Global Investors manages $287B across 417 positions as of Q4 2018. Top holdings: ABBV (5.6%), MSFT (3.9%), META (3.2%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 4/5.0.
Active quarter - 415 new positions, 0 exits, 0 increased. Top move: ABBV (NEW, conviction 98). Portfolio: $287.0B across 417 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer